Back to Results
First PageMeta Content



Pre-Exposure Prophylaxis (PrEP): A primer for primary care providers Daily emtricitabine/tenofovir (Truvada®) is safe and effective for reducing the risk of HIV acquisition in sexually active men and women and injection
Add to Reading List

Open Document

File Size: 359,31 KB

Share Result on Facebook